You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 43 No. 5, May 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reliability and Validity of the Symptoms of Major Depressive Illness

Carolyn Mazure, PhD; J. Craig Nelson, MD; Lawrence H. Price, MD

Arch Gen Psychiatry. 1986;43(5):451-456.


Abstract

• In two consecutive studies, we examined the interrater reliability and then the concurrent validity of interview ratings for individual symptoms of major depressive illness. The concurrent validity of symptoms was determined by assessing the degree to which symptoms observed or reported during an interview were observed in daily behavior. Results indicated that most signs and symptoms of major depression and melancholia can be reliably rated by clinicians during a semistructured interview. Ratings of observable symptoms (signs) assessed during the interview were valid indicators of dysfunction observed in daily behavior. Several but not all ratings based on patient report of symptoms were at variance with observation. These discordant patient-reported symptoms may have value as subjective reports but were not accurate descriptions of observed dysfunction.



Author Affiliations

From the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.


Footnotes

Accepted for publication Aug 19, 1985.

Reprint requests to Yale-New Haven Hospital, MU10-7, 20 York St, New Haven, CT 06504 (Dr Mazure).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Assessment of outcome in depression
Nelson et al.
J Psychopharmacol 2006;20:47-53.
ABSTRACT  

Increased Cortical GABA Concentrations in Depressed Patients Receiving ECT
Sanacora et al.
Am. J. Psychiatry 2003;160:577-579.
ABSTRACT | FULL TEXT  

Reductions in Occipital Cortex GABA Levels in Panic Disorder Detected With 1H-Magnetic Resonance Spectroscopy
Goddard et al.
Arch Gen Psychiatry 2001;58:556-561.
ABSTRACT | FULL TEXT  

A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor-Refractory Obsessive-compulsive Disorder
McDougle et al.
Arch Gen Psychiatry 2000;57:794-801.
ABSTRACT | FULL TEXT  

Adverse Life Events and Cognitive-Personality Characteristics in the Prediction of Major Depression and Antidepressant Response
Mazure et al.
Am. J. Psychiatry 2000;157:896-903.
ABSTRACT | FULL TEXT  

Transient Depressive Relapse Induced by Catecholamine Depletion: Potential Phenotypic Vulnerability Marker?
Berman et al.
Arch Gen Psychiatry 1999;56:395-403.
ABSTRACT | FULL TEXT  

Clinical and Biochemical Effects of Catecholamine Depletion on Antidepressant-Induced Remission of Depression
Miller et al.
Arch Gen Psychiatry 1996;53:117-128.
ABSTRACT  

Serotonin and the Neurobiology of Depression: Effects of Tryptophan Depletion in Drug-Free Depressed Patients
Delgado et al.
Arch Gen Psychiatry 1994;51:865-874.
ABSTRACT  

Haloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder: A Double-blind, Placebo-Controlled Study in Patients With and Without Tics
McDougle et al.
Arch Gen Psychiatry 1994;51:302-308.
ABSTRACT  

Tryptophan Depletion in Patients With Obsessive-Compulsive Disorder Who Respond to Serotonin Reuptake Inhibitors
Barr et al.
Arch Gen Psychiatry 1994;51:309-317.
ABSTRACT  

A Preliminary, Open Study of the Combination of Fluoxetine and Desipramine for Rapid Treatment of Major Depression
Nelson et al.
Arch Gen Psychiatry 1991;48:303-307.
ABSTRACT  

Serotonin Function and the Mechanism of Antidepressant Action: Reversal of Antidepressant-Induced Remission by Rapid Depletion of Plasma Tryptophan
Delgado et al.
Arch Gen Psychiatry 1990;47:411-418.
ABSTRACT  

The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman et al.
Arch Gen Psychiatry 1989;46:1006-1011.
ABSTRACT  

Effects of Desipramine and Fluvoxamine Treatment on the Prolactin Response to Tryptophan: Serotonergic Function and the Mechanism of Antidepressant Action
Price et al.
Arch Gen Psychiatry 1989;46:625-631.
ABSTRACT  

Lithium Treatment and Serotoninergic Function: Neuroendocrine and Behavioral Responses to Intravenous Tryptophan in Affective Disorder
Price et al.
Arch Gen Psychiatry 1989;46:13-19.
ABSTRACT  

Efficacy of Fluvoxamine in Obsessive-Compulsive Disorder: A Double-blind Comparison With Placebo
Goodman et al.
Arch Gen Psychiatry 1989;46:36-44.
ABSTRACT  

Does the Dexamethasone Suppression Test Relate to Subtypes, Factors, Symptoms, or Severity?
Miller and Nelson
Arch Gen Psychiatry 1987;44:769-774.
ABSTRACT  

{alpha}2-Adrenergic Receptor Function in Depression: The Cortisol Response to Yohimbine
Price et al.
Arch Gen Psychiatry 1986;43:849-858.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.